RAPP - Latest News
Rapport Therapeutics, Inc. Common Stock (RAPP), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.39B. Beta to the broader market is 0.82.
The article list below shows the most recent RAPP headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent RAPP Headlines
Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss
zacks.com - May 7, 2026
Rapport Therapeutics, Inc. (RAPP) came out with a quarterly loss of $0.
Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update
globenewswire.com - May 7, 2026
Phase 2a follow-up period data for RAP-219 in focal onset seizures (FOS) demonstrated sustained seizure reduction, including a 90% median reduction in
Modalités de mise à disposition du rapport financier annuel 2025
globenewswire.com - Apr 30, 2026
MODALITES DE MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 La société AdVini annonce avoir mis à la disposition du public et déposé auprès de l'
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
globenewswire.com - Apr 30, 2026
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Dijon, France le 30 avril 2026 (17h45 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), soci
Rapport Insider Sells $17.2 Million as Stock Surges 230% in a Year and Phase 3 Trials Near
fool.com - Apr 27, 2026
This Boston-based biotech innovator in CNS disorders just reported significant insider selling amid a year of standout stock gains.
How News Affects RAPP Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track RAPP's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked RAPP news questions
- What is the latest RAPP news headline?
- The most recent RAPP headline (May 7, 2026) is "Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the RAPP news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What RAPP news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual RAPP options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.